Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma:A Rare Cancer Network study

被引:1
|
作者
Alessandra Franzetti Pellanda [1 ,2 ]
Berardino De Bari [1 ,3 ]
Elisabeth Deniaud-Alexandre [4 ,5 ]
Marco Krengli [6 ]
Paul Van Houtte [7 ]
Antonella Richetti [8 ,9 ]
Salvador Villà [10 ]
Hadassah Goldberg [11 ]
Ewa Szutowicz-Zielińska [12 ]
Michel Bolla [13 ]
Heidi Rutten [14 ]
Marc Van Eijkeren [15 ]
Philip Poortmans [14 ,16 ]
Guido Henke [17 ]
Yavuz Anacak [18 ]
Steve Chan [19 ]
Christine Landmann [20 ]
Carine Kirkove [21 ]
Luciano Scandolaro [22 ]
Jacques Bernier [23 ,24 ]
René-Olivier Mirimanoff [1 ]
Mahmut Ozsahin [1 ]
机构
[1] Centre Hospitalier Universitaire Vaudois (CHUV)
[2] Clinica Luganese Moncucco  3. Centre Hospitalier Régional Universitaire “Jean Minjoz”,INSERM
[3] H?pital Tenon
[4] Centre Hospitalier Départemental
[5] Università degli Studi del Piemonte Orientale e Ospedale Maggiore della Carità
[6] Institut Jules Bordet  8. Ospedale di Circolo  9. Istituto Oncologico della Svizzera Italiana,EOC 
关键词
Uterine leiomyosarcoma; prognostic factors; radiotherapy; overall survival; local control;
D O I
暂无
中图分类号
R737.33 [子宫肿瘤];
学科分类号
摘要
Objective: Primary uterine leiomyosarcomas(ULMS) are rare,and the optimal treatment is controversial.We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.Methods: We retrospectively collected data of 110 women treated in 19 institutions of the Rare Cancer Network(RCN).Inclusion criteria consisted of a pathology report confirming the diagnosis of ULMS,aged 18–80 years,complete International Federation of Gynecology and Obstetrics(FIGO) stage information,complete information on treatment,and a minimum follow-up of 6 months.Local control(LC) and locoregional control(LRC),overall survival(OS) and disease-free survival(DFS) rates were computed using the Kaplan-Meier method.Univariate analysis was implemented using the log rank test,and multivariate analysis using the Cox model.Results: All patients underwent surgery.Seventy-five patients(68%) received adjuvant radiotherapy(RT),including brachytherapy in 18(16%).Seventeen patients(15%) received adjuvant chemotherapy.Median follow-up was 58(range,6–240) months.Five-year OS and DFS rates were 50% and 34%,and LC and LRC rates were 88%and 72%,respectively.On multivariate analysis,independent favorable prognostic factors were younger age,FIGO stage I,small tumor size,previous uterine disease,and no vascular invasion for OS and DFS.FIGO stage was the only favorable factor influencing LRC.Adjuvant local or systemic treatments did not improve the outcomes.Eight patients treated with RT presented a grade 3 acute toxicity,and only one patient with grade 3 late toxicity.Conclusions: In this large population of primary ULMS patients,we found good results in terms of LC and LRC.Nevertheless,OS remains poor,mainly due to the occurrence of distant metastases.An early diagnosis seemed to improve the prognosis of the patients.Adjuvant local or systemic treatments,or more aggressive surgicalprocedures such as the Wertheim procedure,did not seem to impact the outcome.
引用
收藏
页码:521 / 532
页数:12
相关论文
共 50 条
  • [1] Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study
    Pellanda, Alessandra Franzetti
    De Bari, Berardino
    Deniaud-Alexandre, Elisabeth
    Krengli, Marco
    Van Houtte, Paul
    Richetti, Antonella
    Villa, Salvador
    Goldberg, Hadassah
    Szutowicz-Zielinska, Ewa
    Bolla, Michel
    Rutten, Heidi
    Van Eijkeren, Marc
    Poortmans, Philip
    Henke, Guido
    Anacak, Yavuz
    Chan, Steve
    Landmann, Christine
    Kirkove, Carine
    Scandolaro, Luciano
    Bernier, Jacques
    Mirimanoff, Rene-Olivier
    Ozsahin, Mahmut
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (06) : 521 - 532
  • [2] Outcome and prognostic factors in primary uterine leiomyosarcoma: a rare cancer network study
    Pellanda, AF
    Ozsahin, M
    Deniaud, E
    Krengli, M
    Van Houtte, P
    Richetti, A
    Villa, S
    Mirimanoff, RO
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 115 - 115
  • [3] Outcome and prognostic factors in orbital lymphoma: A rare cancer network study on 90 consecutive patients treated with radiotherapy
    Martinet, S
    Ozsahin, M
    Belkacemi, Y
    Landmann, C
    Poortmans, P
    Oehlere, C
    Scandolaro, L
    Krengli, M
    Maingon, P
    Miralbell, R
    Studer, G
    Chauvet, B
    Marnitz, S
    Zouhair, A
    Mirimanoff, RO
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (04): : 892 - 898
  • [4] Outcome and prognostic factors of primary breast sarcoma: A rare cancer network study
    Bousquet, G
    Confavreux, C
    Tunon, D
    Magne, N
    Poortmans, P
    Senkus, E
    De Lafontan, B
    Azria, D
    Lagneau, E
    Ozsahin, M
    Belkacemi, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S255 - S256
  • [5] Outcome and prognostic factors of primary breast sarcoma: a rare cancer network
    Bousquet, G
    Confavreux, C
    de Lara, CT
    Magne, N
    Poortmans, P
    Senkus, E
    De Lafontan, B
    Azria, D
    Lagneau, E
    Ozsahin, M
    Belkacemi, Y
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S15 - S16
  • [6] Primary spinal epidural lymphoma: Patients' profile, outcome, and prognostic factors: A multicenter rare cancer network study
    Monnard, Virginie
    Sun, Alex
    Epelbaum, Ron
    Poortmans, Philip
    Miller, Robert C.
    Verschueren, Tom
    Scandolaro, Luciano
    Villa, Salvador
    Majno, Sabine Balmer
    Ostermann, Sandrine
    Ozsahin, Mahmut
    Mirimanoff, Rent-Olivier
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 817 - 823
  • [7] Primary Pineal Tumors; Outcome and prognostic factors: A study from the rare cancer network (RCN)
    Villa, S.
    Miller, R. C.
    Krengli, M.
    Abousaris, H.
    Baumert, B. O.
    Servagi-Vernat, S.
    Igdem, s.
    Lucas, A.
    Boluda, S.
    Mirimanoff, R. O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S224 - S224
  • [8] Primary pineal tumors: outcome and prognostic factors—a study from the Rare Cancer Network (RCN)
    Salvador Villà
    Robert C. Miller
    Marco Krengli
    Huda Abusaris
    Brigitta G. Baumert
    Stephanie Servagi-Vernat
    Sefik Igdem
    Anna Lucas
    Susanna Boluda
    René O. Mirimanoff
    Clinical and Translational Oncology, 2012, 14 : 827 - 834
  • [9] OUTCOME AND PROGNOSTIC FACTORS IN OLFACTORY NEUROBLASTOMA: A RARE CANCER NETWORK STUDY
    Ozsahin, Mahmut
    Gruber, Guenther
    Olszyk, Olimpia
    Karakoyun-Celik, Omur
    Pehlivan, Berrin
    Azria, David
    Roelandts, Martine
    Kaanders, Johannes H. A. M.
    Cengiz, Mustafa
    Krengli, Marco
    Matzinger, Oscar
    Zouhair, Abderrahim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04): : 992 - 997
  • [10] Primary pineal tumors: outcome and prognostic factors-a study from the Rare Cancer Network (RCN)
    Villa, Salvador
    Miller, Robert C.
    Krengli, Marco
    Abusaris, Huda
    Baumert, Brigitta G.
    Servagi-Vernat, Stephanie
    Igdem, Sefik
    Lucas, Anna
    Boluda, Susanna
    Mirimanoff, Rene O.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (11): : 827 - 834